Trials / Completed
CompletedNCT02073669
Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults
Better Identification of Latent Tuberculosis Infection Among Israeli Young Adults by Comparison Skin Tests and Interferon Gamma Releasing Assays (IGRA)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 115 (actual)
- Sponsor
- Sheba Medical Center · Other Government
- Sex
- All
- Age
- 18 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
The aim of study is to evaluate the prevalence of latent TB in second generation immigrants from countries with high incidence of tuberculosis (above 20 of 100,000) compare to the control native Israelis without a family member who was born in a country with high incidence of tuberculosis. Using study questionnaire IGRA and tuberculin skin test the investigators expect that the second generation immigrants group will have more positive IGRA test than the control native group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA) |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2018-08-01
- Completion
- 2018-11-01
- First posted
- 2014-02-27
- Last updated
- 2019-01-25
Locations
2 sites across 1 country: Israel
Source: ClinicalTrials.gov record NCT02073669. Inclusion in this directory is not an endorsement.